Published research on MOTS-c: record counts, recent publications, reviews and registered studies, pulled from PubMed and ClinicalTrials.gov. Part of other.
Ask TinaTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Registered studies by status: 3 recruiting, 1 active not recruiting, 0 completed.
Number of PubMed records mentioning MOTS-c, 2016 to 2026 (2026 is year to date).
Most recently started of 5 ClinicalTrials.gov entries.
Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal TransplantationNCT07678073 · Recruiting · NA · started 2026-03-01MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/ObesityNCT07505745 · Recruiting · Phase 2 · started 2026-02-02The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their CombinationNCT03878706 · Recruiting · started 2017-11-03Cohort Of DEafness-gene ScreeningNCT06133946 · Active Not Recruiting · started 2016-01-01Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CADNCT04027712 · Unknown · started 2014-01-01Primary data for your own interpretation: published studies and regulator documents. No publisher opinion pieces.
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med · 2026 Apr 12 · Mendias CL et al. · PubMedSynthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards.Int J Pharm Compd · 2026 Jul-Aug · Willis J et al. · PubMedMOTS-c in type 2 diabetes mellitus: From risk factors to cardiac complications and potential treatment.Life Sci · 2025 Oct 11 · Fang T et al. · PubMedExercise-Induced Muscle-Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging.Pharmaceuticals (Basel) · 2025 Aug 19 · Tero-Vescan A et al. · PubMedβ-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.J Thromb Thrombolysis · 2020 Apr · Ikonomidis I et al. · PubMedAsk Tina for links to further coverageTina is an AI research guide who has read the published research collected here and shares it as objectively as she can, for free. She's not a doctor and doesn't give medical advice.
Third-party links, listed for reference. Educational information only, not medical advice. Hypnotic Dose does not endorse any product.